Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.180
-0.355 (-14.00%)
At close: Aug 14, 2026, 4:00 PM EDT
2.190
+0.010 (0.46%)
After-hours: Aug 14, 2026, 6:02 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $202.05 million as of August 14, 2026. Its market cap has decreased by -1.51% in one year.
Market Cap
202.05M
Enterprise Value
188.46M
1-Year Change
-1.51%
Ranking
Category
Stock Price
$2.18
ChartMarket Cap Chart
Since October 18, 2019, Innate Pharma's market cap has decreased from $480.08M to $202.05M, a decrease of -57.91%. That is a compound annual growth rate of -11.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 202.05M | 16.53% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adagene | 245.79M |
| Capricor Therapeutics | 243.81M |
| Niagen Bioscience | 241.84M |
| Greenwich LifeSciences | 240.43M |
| Camp4 Therapeutics | 233.67M |
| Protara Therapeutics | 232.84M |
| Galectin Therapeutics | 232.47M |
| Compugen | 228.29M |